Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.53058 | 21 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.5075 | 22 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.50944 | 22 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.45471 | 21 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.45026 | 21 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.57326 | 22 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.52631 | 21 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.48479 | 21 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.47296 | 21 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.49499 | 21 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.49141 | 21 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.47758 | 21 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.50069 | 21 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.49542 | 21 |